But cancer experts say that it's not clear that it was the just the drug that shrank Carter's tumors because he was also treated with radiation to his brain, and had a tumor on his liver removed, NBC News reports..
Keytruda is the first cancer drug to take a different approach, known generically as pembrolizumab, the drug targets the activity of two genes and the interaction between them allows some tumors to escape detection and lets the immune cells do their work by eating the tumor cells, said NBC News.
The Food and Drug Administration gave Keytruda accelerated approval in 2014 for patients whose melanoma has spread on the basis of a large study that showed the drug could shrink the tumors of about a third of patients by as much as 90 percent, NBC News reported.
Click here to read the Daily Voice story when Carter announced his cancer.
Click here to read the entire story.
Click here to follow Daily Voice Armonk and receive free news updates.